European Union

EPO Patent Publication: Enterotoxigenic E. coli Fusion Antigen

The European Patent Office has published a patent application (EP2026030712A1) related to enterotoxigenic E. coli fusion antigen proteins and their use. The publication date is March 18, 2026, and the inventors have not yet been designated.

EPO Patent Publication: Rock Hyrax IPSC Generation Methods

The European Patent Office has published a patent application (EP2026030659A1) detailing methods for generating induced pluripotent stem cells (IPSC) from rock hyrax. The publication date is March 18, 2026, and it includes IPC classifications related to cell culture and genetic manipulation.

EPO Patent Publication: Expanding NK Cells In Vitro

The European Patent Office has published patent application EP2026030665A1 concerning methods for expanding NK cells in vitro using feeder cell-free systems. This publication details specific IPC classifications related to cell culture and pharmaceutical compositions.

EPO Patent Publication: Fecal Microbiome Spatial Characterization

The European Patent Office has published patent application EP2026030670A1 concerning the spatial characterization of the fecal microbiome. The publication date is March 18, 2026, and it includes various International Patent Classifications related to biotechnology and medical applications.

EPO Patent Publication EP2026030684A1 on Exosome Populations

The European Patent Office has published patent application EP2026030684A1 concerning exosome populations with glyco-modified RNAs and their methods of use. The publication date is March 18, 2026, and it relates to advancements in biotechnology and potential therapeutic applications.

EPO Patent Grant: Neuropeptide Vectors for Epilepsy Treatment

The European Patent Office has granted patent EP3472196B1 for neuropeptide-expressing vectors and methods for treating epilepsy. The patent lists Regine Heilbronn and Christoph Schwarzer as inventors and is effective March 18, 2026.

EPO Patent Grant EP3039131B1: Enzyme Composition and Uses

The European Patent Office has granted patent EP3039131B1 for an enzyme composition and its uses. The patent was published on March 18, 2026, and covers various enzyme classifications relevant to biotechnology and industrial processes.

EPO Patent Granted: Nerve Tissue Production Method EP3211072B1

The European Patent Office has granted patent EP3211072B1 for a method of producing nerve tissue. The patent, listing multiple inventors, is effective March 18, 2026, and applies to designated states within the European Union.

EPO Patent Grant for Chymosin Variants with Improved Milk-Clotting Properties

The European Patent Office has granted patent EP3110948B1 for chymosin variants with improved milk-clotting properties. This patent covers innovations related to biotechnology and food production, impacting the development and commercialization of dairy processing enzymes.

EPO Patent Grant for Nematode Control Methods

The European Patent Office has granted patent EP3531835B1 for methods of controlling nematodes. The patent, which lists multiple inventors, covers specific materials and methods related to nematode control and is effective March 18, 2026.